Citation: Katya Richardson, Beate Sander, Hongbin Guo, Amy Greer, Jane Heffernan. Tuberculosis in Canada: Detection, Intervention and Compliance[J]. AIMS Public Health, 2014, 1(4): 241-255. doi: 10.3934/publichealth.2014.4.241
[1] | Dubos RJ (1951) The white plague: tuberculosis, man, and society. Boston: Little, Brown and Company. |
[2] | Daniel TM (2006) The history of tuberculosis. Respir Med 100(11): 1862-1870. |
[3] | 14. Dawar M, Clark M, Deeks SL, et al. (2004) A fresh look at an old vaccine: does BCG have a role in 21st century Canada? Int J Circumpolar Health 62): 230-236. |
[4] | 15. Sandy J, Richardson R, Warman A, et al. (2007) Mycobacterium tuberculosis infection in first nations preschool children in Alberta Implications for BCG (Bacilli Calmette-Guérin) vaccine withdrawal. Can J Public Health 98(2): 116-120. |
[5] | 17. Wong T (2012) TB: public health implementation science. Tuberculosis in Canada: detection, intervention and compliance. Ottawa: Centre for Disease Modeling and the Public Health Agency of Canada. |
[6] | 18. Wobeser W (2012) Interferon Gamma Release Assay (IGRA) Screening in Correctional Facilities. Tuberculosis in Canada: Detection, Intervention and Compliance. Ottawa: Centre for Disease Modelling and the Public Health Agency of Canada. |
[7] | 19. Johnston J (2012) Active TB in Foreign Born Populations. Tuberculosis in Canada: Detection, Intervention and Compliance. Ottawa: Centre for Disease Modelling and the Public Health Agency of Canada. |
[8] | 20. Soualhine H (2012) Molecular diagnostic tools for tuberculosis control. Tuberculosis in Canada: Detection, Intervention and Compliance. Ottawa: Centre for Disease Modelling and the Public Health Agency of Canada. |
[9] | 21. World Health Organization (2013) Rapid implementation of the Xpert MTB/RIF diagnostic test: technical and operational “how-to” practical considerations. World Health Organization, 2013. Available from: http://whqlibdoc. who. int/publications/2011/89241501569_eng. pdf. Web. 5 Jul 2013. |
[10] | 22. Gardy J (2012) Quantifying Endogenous Transmission of TB in Canada: The Impact of Next-generation Genome Sequencing. Tuberculosis in Canada: Detection, Intervention and Compliance. Ottawa: Centre for Disease Modelling and the Public Health Agency of Canada. |
[11] | 24. Rea E (2012) Video Directly Observed Therapy (VDOT). OPHA Annual Fall Forum 2012 eHealth Innovations in Public Health. Toronto: Ontario Public Health Associations. |
[12] | 25. Centers for Disease Control and Prevention (2011) Morbidity and Mortality Weekly Report. Recommendations for Use of an Isoniazid-Rifapentine Regimen with Direct Observation to Treat Latent Mycobacterium tuberculosis Infection. MMWR 60(48): 1650-1653. |
[13] | 26. Sterling TR, Elsa V, et al. (2011) Three Months of Rifapentine and Isoniazid for latent tuberculosis infection. N Engl J Med 365(23): 2155-2166. |
[14] | 27. Rea E (2012) TB Control in Toronto. Tuberculosis in Canada: Detection, Intervention and Compliance. Ottawa: Centre for Disease Modelling and the Public Health Agency of Canada. |
[15] | 28. Public Health Agency of Canada (2013) Tuberculosis in Canada 2010, Pre-Release. Public Health Agency of Canada, 2012. Available from: http://www. phac-aspc. gc. ca/tbpc-latb/pubs/tbcan10pre/index-eng. php. Web. 28 Nov 2013. |
[16] | 29. Pottie K, Greenaway C, Feightner J, et al. (2011) Evidence-based clinical guidelines for immigrants and refugees. CMAJ 183(12): |
[17] | 30. Varughese B (2012) Preventing Tuberculosis in the Foreign-Born Population of Canada: A Mathematical Modeling Study. Tuberculosis in Canada: Detection, Intervention and Compliance. Ottawa: Centre for Disease Modelling and the Public Health Agency of Canada. |
[18] | 31. Turner G (2012) TB in Inuit Nunagat: From context to Inuit designed and led solutions. Tuberculosis in Canada: Detection, Intervention and Compliance. Ottawa: Centre for Disease Modelling and the Public Health Agency of Canada. |
[19] | 32. MacLeod M, Browne AJ, Leipert B (8) Issues for nurses in rural and remote Canada. J Rural Health 6(2): 72-78. |
[20] | 33. Health Council of Canada (3) Canada's most vulnerable: Improving health care for First Nations, Inuit, and Métis seniors. Health Council of Canada, 2013. Available from: http://www. hhr-rhs. ca/images/stories/Senior_AB_Report_2013_EN_final. |
[21] | 34. Moffatt J, Maria M, Long (2013) Sanitoriums and the Canadian Colonial Legacy: The Untold Experiences of Tuberculosis Treatment. Qual Life Res 23(12): 1591-1599. |
[22] | 35. Brassard P, Anderson KK, Menzies D, et al. (2008) Knowledge and Perceptions of Tuberculosis Among a Sample of Urban Aboriginal People. J Comm Health 33(4): 192-198. |
[23] | 37. Rees S, Jocelyne C (2012) Health Canada's Strategy against Tuberculosis for First Nations On-Reserve. Tuberculosis in Canada: Detection, Intervention and Compliance. Ottawa: Centre for Disease Modelling and the Public Health Agency of Canada. |
[24] | 38. Alvarez G (2012) TAIMA TB (STOP TB Inuktitut) in Iqaluit, Nunavut. Tuberculosis in Canada: Detection, Intervention and Compliance. Ottawa: Centre for Disease Modelling and the Public Health Agency of Canada. |
[25] | 39. Gaetz S (2012) Homelessness, Social Exclusion, and the Risk of Tuberculosis Infection. Tuberculosis in Canada: Detection, Intervention and Compliance. Ottawa: Centre for Disease Modelling and the Public Health Agency of Canada. |
[26] | 40. Ronald A (2012) Population Health in the 21st Century. Tuberculosis in Canada: Detection, Intervention and Compliance. Ottawa: Centre for Disease Modelling and the Public Health Agency of Canada. |
[27] | 41. Du Y (2012) Mathematical Model for Tuberculosis at Different Scales. Tuberculosis in Canada: Detection, Intervention and Compliance. Ottawa: Centre for Disease Modelling and the Public Health Agency of Canada. |
[28] | 42. Wigginton J, Kirschner D (2001) A model to predict cell-mediated immune regulatory mechanisms during human infection with Mycobacterium tuberculosis. J Immunol 166(3): 1951-1976. |
[29] | 43. Marino S, Kirschner DE (2004) The Human Immune Response to Mycobacterium tuberculosis in lung and lymph node. J Theor Biol 227(4): 463-486. |
[30] | 44. Magombedze G, Garira W, Mwenje E (2006) Modelling the human immune response mechanisms to Mycobacterium tuberculosis infection in the lungs. Math Biosci Eng 3(4): 661. |
[31] | 45. Alavez-Ramírez J, Castellanos JR, Esteva L, et al. (2007) Within-host population dynamics of antibiotic-resistant M. tuberculosis. Math Med Biol 24(1): 35-56. |